Abstract Background & Aims Patients with inflammatory bowel disease (IBD) may be at
increased risk of some vaccine-preventable diseases. The effectiveness and safety of …

Approximately one out of every 88 seniors has inflammatory bowel disease (IBD), and this is
expected to increase in the future. They are more likely to have left-sided disease in …

BACKGROUND Patients with immune-mediated diseases, such as juvenile idiopathic
arthritis (JIA) and inflammatory bowel disease (IBD) are at increased risk of developing …

The therapeutic landscape for inflammatory bowel disease (IBD) has changed considerably
over the past two decades, owing to the development and widespread penetration of …

Immunosuppressive therapies can affect the immune response to or safety of vaccination in
patients with inflammatory bowel disease (IBD). The appropriateness of vaccination should …

Background There is evidence that SARS-CoV2 infection can increase the risk of herpes
zoster (HZ) in the general population. However, the risk in patients with inflammatory bowel …

Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
unclassified inflammatory bowel disease, are a group of chronic, immune mediated …

Patients with inflammatory bowel disease (IBD) may be at increased risk of developing
certain vaccine-preventable infections such as influenza and pneumococcal pneumonia …

Background & Aims Guidelines recommend measuring antibody (Ab) titers to hepatitis B
virus (HBV) after vaccination for patients with inflammatory bowel disease (IBD) or celiac …

Background Healthy populations have high rates of sustained vaccine-induced
seroprotection to hepatitis B virus, but previous studies in immunosuppressed patients with …